Dr. John's Health Matters
Welcome to Dr. John's Health Matters blog.
The articles posted here are from various sources who are duly acknowledged. I would appreciate being immediately notified, if any copywritten material needs to be removed. This blog is not intended to replace the qualified advice of a licensed health practitioner. Readers should exercise their own judgment. Enjoy, subscribe, participate and tell others :)
Following:
Navigate
COMING SOON!
Expand all | Collapse all 
Search
Click Tags under Articles
NOTE: SEARCH BY KEYWORD FUNCTIONS BELOW ARE TEMPORARILY MALFUNCTIONING. USE AT OWN RISK.
Or Display Full Article by
Posts tagged "infarction"
Monday, Aug 31st, 2009 ↓Secondhand Smoke Worsens Outcome of Acute Coronary Syndrome →
Aug 28, 2009 (Medscape.com)— - Environmental exposure to tobacco smoke - a known risk factor for myocardial infarction and other acute coronary syndromes (ACS) - can also worsen prognosis after ACS, according to a new study.
“These findings suggest that, by reducing exposure to secondhand smoke, smoke-free legislation may not only reduce the incidence of cardiovascular events, but may also improve prognosis in those who suffer them,” Professors Jill P. Pell and Sally Haw write in a featured editorial published with the study in the September issue of Heart.
For full medical article, see link above.
Tags: secondhand smoke cigarette acute coronary syndrome myocardial infarction risk danger cardiovascular smoker
Hormone therapy fatal in prostate cancer sufferers →
Aug 27, 2009 (Presstv.com)—Hormone-based medications commonly used to treat aggressive prostate cancer may be hazardous for certain men suffering from heart problems.
Previous studies had reported that drugs which block tumor-fueling surges of testosterone can effectively treat aggressive forms of prostate cancer.
A new study, however, finds radiation therapy added with these drugs increase the mortality rate in men already suffering from heart disease.
According to the study published in the Journal of the American Medical Association, neoadjuvant hormone therapy doubles the risk of death in prostate cancer sufferers with coronary artery disease-induced congestive heart failure (CHF) and myocardial infarction (MI).
Such a high mortality risk, however, was not reported among those with no comorbidity or just a single coronary disease risk factor undergoing the treatment.
Scientists concluded that physicians should prescribe hormone therapy with care in men with serious heart diseases. Such men account for only five percent of the male population.
PKH/AA
